These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 16970011)

  • 1. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey.
    Vriens M; Blok H; Fluit A; Troelstra A; Van Der Werken C; Verhoef J
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):782-6. PubMed ID: 12461587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
    J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is certain in the topical eradication of MRSA from carriers?].
    Dziekan G; Mlangeni D; Daschner FD
    Dtsch Med Wochenschr; 2001 Jun; 126(25-26):761-3. PubMed ID: 11455670
    [No Abstract]   [Full Text] [Related]  

  • 7. [Optimising patient isolation due to methicllin-resistant Staphylococcus aureus].
    Kluytmans JA; van den Broek PJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(15):794-6. PubMed ID: 15850268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):586-8; quiz 589-92. PubMed ID: 15761788
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methicillin-resistant Staphylococcus aureus (MRSA) in the community].
    Vonk AG; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):401-7. PubMed ID: 17343138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus.
    Srinivasan S; Sheela D; ; Mathew R; Bazroy J; Kanungo R
    Indian J Med Microbiol; 2006 Jul; 24(3):182-5. PubMed ID: 16912437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus (mrsa) in a Malaysian hospital.
    Cheong I; Tan SC; Wong YH; Zainudin BM; Rahman MZ
    Med J Malaysia; 1994 Mar; 49(1):24-8. PubMed ID: 8057986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.
    Lodise TP; McKinnon PS
    Pharmacotherapy; 2007 Jul; 27(7):1001-12. PubMed ID: 17594206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Kanno H
    Nihon Rinsho; 1990 Oct; 48(10):2355-64. PubMed ID: 2177799
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.
    Tacconelli E; Cataldo MA; Albanese A; Tumbarello M; Arduini E; Spanu T; Fadda G; Anile C; Maira G; Federico G; Cauda R
    J Hosp Infect; 2008 Aug; 69(4):337-44. PubMed ID: 18602187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
    Udo EE; Al-Sweih N; Dhar R; Dimitrov TS; Mokaddas EM; Johny M; Al-Obaid IA; Gomaa HH; Mobasher LA; Rotimi VO; Al-Asar A
    Med Princ Pract; 2008; 17(1):71-5. PubMed ID: 18059105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.